COMP <GO>
CTEV vs PG // 10Y YIELD & FRED MACRO BETA
Claritev Corporation (Class A) (NYSE) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: CTEV 3
— PG 8
■ METRIC PARITY
LAST: $24.00 (0.00%) • MKT CAP: $406.7M
macro-sensitivity
—
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
macro-sensitivity
0.87
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CTEV VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CTEV | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 51.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | 25.40% | +59.60 | CTEV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 2.8x | 16.2x | -13.40 | CTEV | /valuation <GO> |
| Free Cash Flow Yield | -3.02% | 3.77% | -6.79 | PG | /fcf-yield <GO> |
| Operating Margin | 3.00% | 24.30% | -21.30 | PG | /operating-margins <GO> |
| Net Profit Margin | -29.40% | 19.00% | -48.40 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 3.70% | 0.30% | +3.40 | CTEV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.59 | -5.39 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.7 | 60.3 | -13.60 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 21.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $406.7M | $372.21B | -$371.81B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CTEV REV | PG REV | CTEV GROSS % | PG GROSS % | CTEV FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $965.4M | $84.28B | — | 51.2% | -$12.3M | $14.04B |
| FY 2024 | $930.6M | $84.04B | — | 51.4% | -$10.5M | $16.52B |
| FY 2023 | $961.5M | $82.01B | — | — | $171.7M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CTEV // BETA —
PG // BETA 0.87